More than 65 industry players across the world are presently engaged in evaluating the clinical ::>

Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.
To order this 250+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html 
The over USD 5 billion (by 2030) financial opportunity within the endocannabinoid system targeted therapeutics market has been analyzed across the following segments:
Target Disease Indication
Cancer
Genetic Disorders
Neurological Indications
Others


Route of Administration

Oral
Inhalation

Key Geographies

North America
Europe
Asia-Pacific and the Rest of the World
The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030report features the following companies, which we identified to be key players in this domain:

GW Pharmaceuticals

Corbus Pharmaceuticals

Tilray

Tetra Bio-Pharma

Botanix Pharmaceuticals

Kalytera Therapeutics

Therapix Biosciences

Echo Pharmaceuticals

Avicanna

GB Sciences


Table of Contents
1.         PREFACE
 
2.         EXECUTIVE SUMMARY
 
3.         INTRODUCTION
 
4.         MARKET LANDSCAPE: ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS
 
5.         COMPANY PROFILES
 
6.         ACADEMIC GRANTS ANALYSIS
 
7.         PARTNERSHIPS AND COLLABORATIONS
 
8.         MERGERS AND ACQUISITIONS
 
9.         DRUG DEVELOPMENT STRATEGY ANALYSIS
10.        MARKET FORECAST AND OPPORTUNITY ANALYSIS
 
11.        CONCLUDING REMARKS
 
12.        EXECUTIVE INSIGHTS
 
13.        APPENDIX 1: TABULATED DATA
 

14.        APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html


Contact Details
Gaurav Chaudhary
+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

 
 

 

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
1448 Posts

Made with by Mamby